2020
White matter hyperintensities (WMH), also known as leukoaraïosis are very common neuroradiological manifestations in the elderly. The main risk factors (…)
Consulter 
2021
Tissue type Plasminogen Activator (tPA), named alteplase (Actilyse®) under its commercial form, is currently the only pharmacological treatment approved during (…)
Consulter
2021
Tissue plasminogen activator (tPA) is a serine protease involved in fibrinolysis. It is released by endothelial cells, but also expressed (…)
Consulter
2021
Twenty-five years ago, intravenous thrombolysis has revolutionized the care of patients with acute ischemic stroke. Since 2015, randomized clinical trials (…)
Consulter
2021
Factor XII (FXII) is a serine protease that participates in the intrinsic coagulation pathway. Several studies have shown that plasma (…)
Consulter
2021
Ischemic stroke, caused by the interruption of blood flow to the brain and subsequent neuronal death, represents one of the (…)
Consulter
